Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.

作者信息

Henle W, Ho J H, Henle G, Chau J C, Kwan H C

出版信息

Int J Cancer. 1977 Nov 15;20(5):663-72. doi: 10.1002/ijc.2910200504.

DOI:10.1002/ijc.2910200504

PMID:200569

Abstract

摘要

相似文献

Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy.

Int J Cancer. 1977 Nov 15;20(5):663-72. doi: 10.1002/ijc.2910200504.

Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.

IARC Sci Publ (1971). 1978(20):427-37.

Epstein-Barr virus-related antibody. Changes in titers after therapy for nasopharyngeal carcinoma.

Arch Otolaryngol Head Neck Surg. 1990 Nov;116(11):1287-90. doi: 10.1001/archotol.1990.01870110059006.

The significance of serologic test for EB-virus antibody in occult type nasopharyngeal carcinoma.

Auris Nasus Larynx. 1983;10(1):43-8. doi: 10.1016/s0385-8146(83)80027-3.

Anti-Epstein Barr virus antibody in nasopharyngeal carcinoma.

Ann Otol Rhinol Laryngol. 1974 Jan-Feb;83(1):19-25. doi: 10.1177/000348947408300105.

The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: comparison of serum antibody titre, cellular antigen content and histopathology.

Arch Otorhinolaryngol. 1984;239(1):15-23. doi: 10.1007/BF00454258.

[Rhinopharyngeal carcinoma and Epstein-Barr virus: study of a sample of Italian patients].

Acta Otorhinolaryngol Ital. 1985 Jan-Feb;5(1):83-90.

Anti-EBV serologic tests for nasopharyngeal carcinoma.

Laryngoscope. 1980 Dec;90(12):1981-90. doi: 10.1288/00005537-198012000-00009.

Presence of Epstein-Barr virus specific IgA in saliva of nasopharyngeal carcinoma patients: their activity, origin and possible clinical value.

IARC Sci Publ (1971). 1978(20):459-69.

Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.

Acta Virol. 1983 May;27(3):277-81.

引用本文的文献

A Systematic Review on Clinico-Aetiopathological Trends of Nasopharyngeal Cancer in Asia.

Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):4151-4157. doi: 10.1007/s12070-023-03905-z. Epub 2023 Jun 2.

Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma.

Oncologist. 2022 Apr 5;27(4):e340-e349. doi: 10.1093/oncolo/oyac024.

An evaluation of HHV-6 as an etiologic agent in Hodgkin lymphoma and brain cancer using IARC criteria for oncogenicity.

Infect Agent Cancer. 2019 Nov 5;14:31. doi: 10.1186/s13027-019-0248-3. eCollection 2019.

Epithelial cell infection by Epstein-Barr virus.

FEMS Microbiol Rev. 2019 Nov 1;43(6):674-683. doi: 10.1093/femsre/fuz023.

A bacterial genotoxin causes virus reactivation and genomic instability in Epstein-Barr virus infected epithelial cells pointing to a role of co-infection in viral oncogenesis.

Int J Cancer. 2019 Jan 1;144(1):98-109. doi: 10.1002/ijc.31652. Epub 2018 Oct 29.

Perspective: Contribution of Epstein-Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells.

Cancers (Basel). 2018 Apr 17;10(4):120. doi: 10.3390/cancers10040120.

Epstein-Barr virus: more than 50 years old and still providing surprises.

Nat Rev Cancer. 2016 Dec;16(12):789-802. doi: 10.1038/nrc.2016.92. Epub 2016 Sep 30.

Screening for nasopharyngeal cancer.

Cochrane Database Syst Rev. 2015 Nov 6;2015(11):CD008423. doi: 10.1002/14651858.CD008423.pub2.

Epstein-Barr virus and nasopharyngeal carcinoma.

Chin J Cancer. 2014 Dec;33(12):581-90. doi: 10.5732/cjc.014.10197. Epub 2014 Nov 21.

Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.

Oncotarget. 2014 Sep 30;5(18):8583-601. doi: 10.18632/oncotarget.2323.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验